Primary biliary cholangitis: pathogenesis and therapeutic opportunities
The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Abstract
Primary biliary cholangitis is a chronic, seropositive and female-predominant inflammatory and cholestatic liver disease, which has a variable rate of progression towards biliary cirrhosis. Substantial progress has been made in patient risk stratification with the goal of personalized care, including early adoption of next-generation therapy with licensed use of obeticholic acid or off-label fibrate derivatives for those with insufficient benefit from ursodeoxycholic acid, the current first-line drug. The disease biology spans genetic risk, epigenetic changes, dysregulated mucosal immunity and altered biliary epithelial cell function, all of which interact and arise in the context of ill-defined environmental triggers. A current focus of research on nuclear receptor pathway modulation that specifically and potently improves biliary excretion, reduces inflammation and attenuates fibrosis is redefining therapy. Patients are benefiting from pharmacological agonists of farnesoid X receptor and peroxisome proliferator-activated receptors. Immunotherapy remains a challenge, with a lack of target definition, pleiotropic immune pathways and an interplay between hepatic immune responses and cholestasis, wherein bile acid-induced inflammation and fibrosis are dominant clinically. The management of patient symptoms, particularly pruritus, is a notable goal reflected in the development of rational therapy with apical sodium-dependent bile acid transporter inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“diversity of the intestinal microbiome is decreased in treatment-naive primary biliary cholangitis patients 34,35 with a unique intestinal microbiota composed of elevated levels of Enterobacteriaceae, Pseudomonas, Veillonella, and Clostridium, along with reduced levels of Oscillospira and Suterella.33”
From Primary biliary cholangitis. (2024) · cites this paper as [33]
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P., Gilfillan, S., & Lantz, O. (2003) · Nature · doi:10.1038/nature01433 · Cited by 1,139
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131
Self-citationIdentification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Gender Bias in Autoimmunity Is Influenced by Microbiota
Yurkovetskiy, L., Burrows, M., Khan, A. A., Graham, L., Volchkov, P., Becker, L., Antonopoulos, D., Umesaki, Y., & Chervonsky, A. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.013 · Cited by 913
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Dawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Self-citationDifferential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 546
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism
Claudel, T., Staels, B., & Kuipers, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178994.21828.a7 · Cited by 504
Lammers, W. J., van Buuren, H. R., Hirschfield, G. M., Janssen, H. L. A., Invernizzi, P., Mason, A. L., Ponsioen, C. Y., Floreani, A., Corpechot, C., Mayo, M. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.029 · Cited by 498
Self-citationWang, Y.-D., Chen, W.-D., Yu, D., Forman, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 480
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Selmi, C., Mayo, M. J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R. G., Gordon, S. C., Wright, H. I., Zweiban, B., Podda, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.005 · Cited by 480
The bile acid TGR5 membrane receptor: from basic research to clinical application
Duboc, H., Taché, Y., & Hofmann, A. F. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.10.021 · Cited by 473
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15387 · Cited by 468
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
The UK PBC Consortium, Mells, G. F., The Wellcome Trust Case Control Consortium 3, Floyd, J. A. B., Morley, K. I., Cordell, H. J., Franklin, C. S., Shin, S.-Y., Heneghan, M. A., Neuberger, J. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.789 · Cited by 464
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy
Pierce, L. R. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450010075034 · Cited by 428
Th1 and Th17 cells: Adversaries and collaborators
Damsker, J. M., Hansen, A. M., & Caspi, R. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05133.x · Cited by 419
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 419
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Keitel, V., Donner, M., Winandy, S., Kubitz, R., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.171 · Cited by 418
Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’
Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00092-7 · Cited by 411
Safety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Liu, X., Invernizzi, P., Lu, Y., Kosoy, R., Lu, Y., Bianchi, I., Podda, M., Xu, C., Xie, G., Macciardi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.627 · Cited by 398
Self-citationBile acid transporters and regulatory nuclear receptors in the liver and beyond
Halilbasic, E., Claudel, T., & Trauner, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 393
Karlgren, M., Vildhede, A., Norinder, U., Wisniewski, J. R., Kimoto, E., Lai, Y., Haglund, U., & Artursson, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300212s · Cited by 369
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 368
Interleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Monsalve, F. A., Pyarasani, R. D., Delgado-Lopez, F., & Moore-Carrasco, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/549627 · Cited by 354
Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
MARSCHALL, H., WAGNER, M., ZOLLNER, G., FICKERT, P., DICZFALUSY, U., GUMHOLD, J., SILBERT, D., FUCHSBICHLER, A., BENTHIN, L., & GRUNDSTROM, R. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.009 · Cited by 325
Ghonem, N. S., Assis, D. N., & Boyer, J. L. (2015) · Hepatology · doi:10.1002/hep.27744 · Cited by 317
The immunobiology and pathophysiology of primary biliary cirrhosis
Hirschfield, G. M., & Gershwin, M. E. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164014 · Cited by 315
Self-citationShimoda, S., Nakamura, M., Ishibashi, H., Hayashida, K., & Niho, Y. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1835 · Cited by 304
Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., & Auwerx, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015864 · Cited by 298
PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS
Yeaman, S. J., Danner, D. J., Mutimer, D. J., Fussey, S. P. M., James, O. F. W., & Bassendine, M. F. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91894-6 · Cited by 293
Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
Kita, H., Lian, Z.-X., Van de Water, J., He, X.-S., Matsumura, S., Kaplan, M., Luketic, V., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010956 · Cited by 292
The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders #
Keitel, V., Cupisti, K., Ullmer, C., Knoefel, W. T., Kubitz, R., & Häussinger, D. (2009) · Hepatology · doi:10.1002/hep.23032 · Cited by 290
Hartmann, P., Hochrath, K., Horvath, A., Chen, P., Seebauer, C. T., Llorente, C., Wang, L., Alnouti, Y., Fouts, D. E., Stärkel, P., et al. (2018) · Hepatology · doi:10.1002/hep.29676 · Cited by 290
Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.001 · Cited by 289
Self-citationTargeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288
Pathogenesis of cholestatic liver disease and therapeutic approaches
Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.004 · Cited by 287
Self-citationCordell, H. J., Han, Y., Mells, G. F., Li, Y., Hirschfield, G. M., Greene, C. S., Xie, G., Juran, B. D., Zhu, D., Qian, D. C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9019 · Cited by 287
Self-citationAbramovitch, S., Dahan-Bachar, L., Sharvit, E., Weisman, Y., Tov, A. B., Brazowski, E., & Reif, S. (2011) · Gut · doi:10.1136/gut.2010.234666 · Cited by 286
The sodium bile salt cotransport family SLC10
Hagenbuch, B., & Dawson, P. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1130-z · Cited by 266
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
Miller, D. B., & Spence, J. D. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00003 · Cited by 259
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017) · JCI Insight · doi:10.1172/jci.insight.94416 · Cited by 256
Bilirubin in the Liver–Gut Signaling Axis
Hamoud, A.-R., Weaver, L., Stec, D. E., & Hinds, T. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.002 · Cited by 254
Banales, J. M., Sáez, E., Úriz, M., Sarvide, S., Urribarri, A. D., Splinter, P., Tietz Bogert, P. S., Bujanda, L., Prieto, J., Medina, J. F., et al. (2012) · Hepatology · doi:10.1002/hep.25691 · Cited by 250
Effects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis
Corpechot, C., Chrétien, Y., Chazouillères, O., & Poupon, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.019 · Cited by 235
The microbiome and autoimmunity: a paradigm from the gut–liver axis
Li, B., Selmi, C., Tang, R., Gershwin, M. E., & Ma, X. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2018.7 · Cited by 229
Molecular physiology and genetics of Na+-independent SLC4 anion exchangers
Alper, S. L. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.029454 · Cited by 228
Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.
Oude Elferink, R. P., Ottenhoff, R., van Wijland, M., Smit, J. J., Schinkel, A. H., & Groen, A. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117658 · Cited by 227
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
Ihunnah, C. A., Jiang, M., & Xie, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.014 · Cited by 225
Liver Autoimmunity Triggered by Microbial Activation of Natural Killer T Cells
Mattner, J., Savage, P. B., Leung, P., Oertelt, S. S., Wang, V., Trivedi, O., Scanlon, S. T., Pendem, K., Teyton, L., Hart, J., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.009 · Cited by 224
Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology · doi:10.1002/hep.27927 · Cited by 223
Apotopes and the biliary specificity of primary biliary cirrhosis†
Lleo, A., Selmi, C., Invernizzi, P., Podda, M., Coppel, R. L., Mackay, I. R., Gores, G. J., Ansari, A. A., Van de Water, J., & Gershwin, M. E. (2009) · Hepatology · doi:10.1002/hep.22736 · Cited by 222
Baghdasaryan, A., Claudel, T., Gumhold, J., Silbert, D., Adorini, L., Roda, A., Vecchiotti, S., Gonzalez, F. J., Schoonjans, K., Strazzabosco, M., et al. (2011) · Hepatology · doi:10.1002/hep.24537 · Cited by 221
The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice
Lieu, T., Jayaweera, G., Zhao, P., Poole, D. P., Jensen, D., Grace, M., McIntyre, P., Bron, R., Wilson, Y. M., Krappitz, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.042 · Cited by 221
D'Aldebert, E., Biyeyeme Bi Mve, M., Mergey, M., Wendum, D., Firrincieli, D., Coilly, A., Fouassier, L., Corpechot, C., Poupon, R., Housset, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.040 · Cited by 219
Post, S. M., Duez, H., Gervois, P. P., Staels, B., Kuipers, F., & Princen, H. M. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098228 · Cited by 217
Lleo, A., Bowlus, C. L., Yang, G.-X., Invernizzi, P., Podda, M., Van de Water, J., Ansari, A. A., Coppel, R. L., Worman, H. J., Gores, G. J., et al. (2010) · Hepatology · doi:10.1002/hep.23783 · Cited by 216
Yang, C.-Y., Ma, X., Tsuneyama, K., Huang, S., Takahashi, T., Chalasani, N. P., Bowlus, C. L., Yang, G.-X., Leung, P. S. C., Ansari, A. A., et al. (2014) · Hepatology · doi:10.1002/hep.26979 · Cited by 213
Familial primary biliary cirrhosis reassessed: a geographically-based population study
Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80097-x · Cited by 213
Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
Schmidt, D. R., Holmstrom, S. R., Fon Tacer, K., Bookout, A. L., Kliewer, S. A., & Mangelsdorf, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116004 · Cited by 213
Jeffery, H. C., van Wilgenburg, B., Kurioka, A., Parekh, K., Stirling, K., Roberts, S., Dutton, E. E., Hunter, S., Geh, D., Braitch, M. K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.017 · Cited by 212
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver
Oo, Y. H., Banz, V., Kavanagh, D., Liaskou, E., Withers, D. R., Humphreys, E., Reynolds, G. M., Lee-Turner, L., Kalia, N., Hubscher, S. G., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.008 · Cited by 210
Primary biliary cirrhosis is associated with altered hepatic microRNA expression
Padgett, K. A., Lan, R. Y., Leung, P. C., Lleo, A., Dawson, K., Pfeiff, J., Mao, T. K., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.022 · Cited by 209
Decreased Anion Exchanger 2 Immunoreactivity in the Liver of Patients With Primary Biliary Cirrhosis
Medina, J. F., Martínez-Ansó, E., Vázquez, J. J., & Prieto, J. (1997) · Hepatology · doi:10.1002/hep.510250104 · Cited by 207
Hegade, V. S., Kendrick, S. F. W., Dobbins, R. L., Miller, S. R., Thompson, D., Richards, D., Storey, J., Dukes, G. E., Corrigan, M., Oude Elferink, R. P. J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30319-7 · Cited by 206
Self-citationPharmacology of Ursodeoxycholic Acid, an Enterohepatic Drug
Hofmann, A. F. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409103618 · Cited by 205
Salas, J. T., Banales, J. M., Sarvide, S., Recalde, S., Ferrer, A., Uriarte, I., Oude Elferink, R. P. J., Prieto, J., & Medina, J. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.020 · Cited by 195
The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
Péan, N., Doignon, I., Garcin, I., Besnard, A., Julien, B., Liu, B., Branchereau, S., Spraul, A., Guettier, C., Humbert, L., et al. (2013) · Hepatology · doi:10.1002/hep.26463 · Cited by 193
Jones, D., Boudes, P. F., Swain, M. G., Bowlus, C. L., Galambos, M. R., Bacon, B. R., Doerffel, Y., Gitlin, N., Gordon, S. C., Odin, J. A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30246-7 · Cited by 191
Self-citationJung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2004) · Gut · doi:10.1136/gut.53.1.78 · Cited by 188
Amano, K., Leung, P. S. C., Rieger, R., Quan, C., Wang, X., Marik, J., Suen, Y. F., Kurth, M. J., Nantz, M. H., Ansari, A. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5874 · Cited by 187
Akita, H., Suzuki, H., Ito, K., Kinoshita, S., Sato, N., Takikawa, H., & Sugiyama, Y. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00355-2 · Cited by 187
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
Marrapodi, M., & Chiang, J. Y. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32398-1 · Cited by 183
Böttcher, K., Rombouts, K., Saffioti, F., Roccarina, D., Rosselli, M., Hall, A., Luong, T., Tsochatzis, E. A., Thorburn, D., & Pinzani, M. (2018) · Hepatology · doi:10.1002/hep.29782 · Cited by 183
Wakabayashi, K., Lian, Z., Leung, P. S. C., Moritoki, Y., Tsuneyama, K., Kurth, M. J., Lam, K. S., Yoshida, K., Yang, G., Hibi, T., et al. (2008) · Hepatology · doi:10.1002/hep.22390 · Cited by 180
Rieger, R., Leung, P. S. C., Jeddeloh, M. R., Kurth, M. J., Nantz, M. H., Lam, K. S., Barsky, D., Ansari, A. A., Coppel, R. L., Mackay, I. R., et al. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.06.002 · Cited by 172
Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)80515-2 · Cited by 170
The gut microbiome in autoimmunity: Sex matters
Gomez, A., Luckey, D., & Taneja, V. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.04.016 · Cited by 163
Rong, G., Zhou, Y., Xiong, Y., Zhou, L., Geng, H., Jiang, T., Zhu, Y., Lu, H., Zhang, S., Wang, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03898.x · Cited by 162
Khurana, S., & Singh, P. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01326.x · Cited by 162
Cyphert, H. A., Ge, X., Kohan, A. B., Salati, L. M., Zhang, Y., & Hillgartner, F. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375907 · Cited by 161
Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30163-8 · Cited by 155
Self-citationAbnormal expression of anion exchanger genes in primary biliary cirrhosis
Prìeto, J., Qian, C., García, N., Díez, J., & Medina, J. F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90735-u · Cited by 151
Trauner, & Graziadei (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00596.x · Cited by 151
Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity
Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., Nagata, K., Sinal, C. J., Guo, G. L., Gonzalez, F. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210634200 · Cited by 151
Ward, A., Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1984) · Drugs · doi:10.2165/00003495-198427020-00001 · Cited by 148
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
Takeda, K., Kojima, Y., Ikejima, K., Harada, K., Yamashina, S., Okumura, K., Aoyama, T., Frese, S., Ikeda, H., Haynes, N. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802702105 · Cited by 148
Barbier, O., Duran-Sandoval, D., Pineda-Torra, I., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305361200 · Cited by 142
Cloning and characterization of the human soluble adenylyl cyclase
Geng, W., Wang, Z., Zhang, J., Reed, B. Y., Pak, C. Y. C., & Moe, O. W. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00584.2004 · Cited by 141
Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141
Kleinboelting, S., Diaz, A., Moniot, S., van den Heuvel, J., Weyand, M., Levin, L. R., Buck, J., & Steegborn, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322778111 · Cited by 139
Senekeo‐Effenberger, K., Chen, S., Brace‐Sinnokrak, E., Bonzo, J. A., Yueh, M., Argikar, U. A., Kaeding, J., Trottier, J., Remmel, R. P., Ritter, J. K., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013243 · Cited by 137
Yokoyama, T., Komori, A., Nakamura, M., Takii, Y., Kamihira, T., Shimoda, S., Mori, T., Fujiwara, S., Koyabu, M., Taniguchi, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01254.x · Cited by 136
Invernizzi, P., Selmi, C., Poli, F., Frison, S., Floreani, A., Alvaro, D., Almasio, P., Rosina, F., Marzioni, M., Fabris, L., et al. (2008) · Hepatology · doi:10.1002/hep.22567 · Cited by 132
Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis
Teng, S., & Piquette‐Miller, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707235 · Cited by 130
Activation of necroptosis in human and experimental cholestasis
Afonso, M. B., Rodrigues, P. M., Simão, A. L., Ofengeim, D., Carvalho, T., Amaral, J. D., Gaspar, M. M., Cortez-Pinto, H., Castro, R. E., Yuan, J., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.280 · Cited by 130
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 130
Lazaridis, K. N., Juran, B. D., Boe, G. M., Slusser, J. P., de Andrade, M., Homburger, H. A., Ghosh, K., Dickson, R. E., Lindor, K. D., & Petersen, G. M. (2007) · Hepatology · doi:10.1002/hep.21749 · Cited by 128
Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis: Have the Orphans Found a Home?
Ory, D. S. (2004) · Circulation Research · doi:10.1161/01.res.0000143422.83209.be · Cited by 128
Pathogenesis of Kupffer Cells in Cholestatic Liver Injury
Sato, K., Hall, C. M., Glaser, S. S., Francis, H., Meng, F., & Alpini, G. D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.003 · Cited by 127
Sasaki, M., Ikeda, H., Yamaguchi, J., Nakada, S., & Nakanuma, Y. (2008) · Hepatology · doi:10.1002/hep.22348 · Cited by 125
T follicular helper cells in human autoimmunity
Ueno, H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.08.003 · Cited by 125
Chuang, Y.-H., Lian, Z.-X., Tsuneyama, K., Chiang, B.-L., Ansari, A. A., Coppel, R. L., & Eric Gershwin, M. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.04.001 · Cited by 121
Bae, H. R., Leung, P. S. C., Tsuneyama, K., Valencia, J. C., Hodge, D. L., Kim, S., Back, T., Karwan, M., Merchant, A. S., Baba, N., et al. (2016) · Hepatology · doi:10.1002/hep.28641 · Cited by 121
Bile Acid Transport in Sister of P-Glycoprotein (ABCB11) Knockout Mice
Lam, P., Wang, R., & Ling, V. (2005) · Biochemistry · doi:10.1021/bi050943e · Cited by 120
Arenas, F., Hervias, I., Úriz, M., Joplin, R., Prieto, J., & Medina, J. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33156 · Cited by 117
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.008 · Cited by 115
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis
Wang, L., Sun, Y., Zhang, Z., Jia, Y., Zou, Z., Ding, J., Li, Y., Xu, X., Jin, L., Yang, T., et al. (2015) · Hepatology · doi:10.1002/hep.27306 · Cited by 111
Onishi, S., Sakamaki, T., Maeda, T., Iwamura, S., Tomita, A., Saibara, T., & Yamamoto, Y. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80617-8 · Cited by 111
miRNA-21 ablation protects against liver injury and necroptosis in cholestasis
Afonso, M. B., Rodrigues, P. M., Simão, A. L., Gaspar, M. M., Carvalho, T., Borralho, P., Bañales, J. M., Castro, R. E., & Rodrigues, C. M. P. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0019-x · Cited by 111
Jung, D., Fried, M., & Kullak-Ublick, G. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203511200 · Cited by 110
Cx3cl1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis
Shimoda, S., Harada, K., Niiro, H., Taketomi, A., Maehara, Y., Tsuneyama, K., Kikuchi, K., Nakanuma, Y., Mackay, I. R., Gershwin, E. M., et al. (2010) · Hepatology · doi:10.1002/hep.23318 · Cited by 108
Interpreting serological tests in diagnosing autoimmune liver diseases
Invernizzi, P., Lleo, A., & Podda, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979469 · Cited by 107
miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
Arora, H., Qureshi, R., & Park, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064273 · Cited by 106
Apoptosis in response to microbial infection induces autoreactive TH17 cells
Campisi, L., Barbet, G., Ding, Y., Esplugues, E., Flavell, R. A., & Blander, J. M. (2016) · Nature Immunology · doi:10.1038/ni.3512 · Cited by 104
Padgett, K. A., Selmi, C. F., Kenny, T. P., Leung, P. S. C., Balkwill, D. L., Ansari, A. A., Coppel, R. L., & Gershwin, M. E. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.01.012 · Cited by 102
Chuang, Y.-H., Lian, Z.-X., Yang, G.-X., Shu, S.-A., Moritoki, Y., Ridgway, W. M., Ansari, A. A., Kronenberg, M., Flavell, R. A., Gao, B., et al. (2008) · Hepatology · doi:10.1002/hep.22052 · Cited by 101
Haczeyni, F., Wang, H., Barn, V., Mridha, A. R., Yeh, M. M., Haigh, W. G., Ioannou, G. N., Choi, Y., McWherter, C. A., Teoh, N. C. ‐., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1072 · Cited by 101
Grigorian, A. Y., Mardini, H. E., Corpechot, C., Poupon, R., & Levy, C. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.02.011 · Cited by 99
Ando, Y., Yang, G.-X., Kenny, T. P., Kawata, K., Zhang, W., Huang, W., Leung, P. S. C., Lian, Z.-X., Okazaki, K., Ansari, A. A., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.013 · Cited by 98
Harada, K., Isse, K., & Nakanuma, Y. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023507 · Cited by 98
Mayo, M. J., Pockros, P. J., Jones, D., Bowlus, C. L., Levy, C., Patanwala, I., Bacon, B., Luketic, V., Vuppalanchi, R., Medendorp, S., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1305 · Cited by 97
Self-citationThomas, M., Burk, O., Klumpp, B., Kandel, B. A., Damm, G., Weiß, T. S., Klein, K., Schwab, M. G., & Zanger, U. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082503 · Cited by 95
Erice, O., Munoz‐Garrido, P., Vaquero, J., Perugorria, M. J., Fernandez‐Barrena, M. G., Saez, E., Santos‐Laso, A., Arbelaiz, A., Jimenez‐Agüero, R., Fernandez‐Irigoyen, J., et al. (2018) · Hepatology · doi:10.1002/hep.29533 · Cited by 95
Expression of bile acid receptor TGR5 in gastric adenocarcinoma
Cao, W., Tian, W., Hong, J., Li, D., Tavares, R., Noble, L., Moss, S. F., & Resnick, M. B. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2012 · Cited by 93
Shimoda, S., Miyakawa, H., Nakamura, M., Ishibashi, H., Kikuchi, K., Kita, H., Niiro, H., Arinobu, Y., Ono, N., Mackay, I. R., et al. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.05.003 · Cited by 92
Environmental factors in primary biliary cirrhosis
Juran, B., & Lazaridis, K. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383726 · Cited by 89
Vrins, C. L. J., van der Velde, A. E., van den Oever, K., Levels, J. H. M., Huet, S., Oude Elferink, R. P. J., Kuipers, F., & Groen, A. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800579-jlr200 · Cited by 89
Farnesoid X receptor modulators 2014-present: a patent review
Sepe, V., Distrutti, E., Fiorucci, S., & Zampella, A. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1459569 · Cited by 88
Ghonem, N. S., Ananthanarayanan, M., Soroka, C. J., & Boyer, J. L. (2014) · Hepatology · doi:10.1002/hep.26894 · Cited by 87
Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality.
Hamlyn, A. N., Macklon, A. F., & James, O. (1983) · Gut · doi:10.1136/gut.24.10.940 · Cited by 87
Sepe, V., Renga, B., Festa, C., D’Amore, C., Masullo, D., Cipriani, S., Di Leva, F. S., Monti, M. C., Novellino, E., Limongelli, V., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500889f · Cited by 87
Al-Dury, S., Wahlström, A., Wahlin, S., Langedijk, J., Elferink, R. O., Ståhlman, M., & Marschall, H.-U. (2018) · Scientific Reports · doi:10.1038/s41598-018-25214-0 · Cited by 85
Human leukocyte antigen in primary biliary cirrhosis: An old story now reviving
Invernizzi, P. (2011) · Hepatology · doi:10.1002/hep.24414 · Cited by 84
Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis
Probert, P. M., Leitch, A. C., Dunn, M. P., Meyer, S. K., Palmer, J. M., Abdelghany, T. M., Lakey, A. F., Cooke, M. P., Talbot, H., Wills, C., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.027 · Cited by 84
Natural killer cells regulate T cell immune responses in primary biliary cirrhosis
Shimoda, S., Hisamoto, S., Harada, K., Iwasaka, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Shirabe, K., Ikegami, T., et al. (2015) · Hepatology · doi:10.1002/hep.28122 · Cited by 82
Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506
Ananthanarayanan, M., Bañales, J. M., Guerra, M. T., Spirlì, C., Muñoz-Garrido, P., Mitchell-Richards, K., Tafur, D., Sáez, E., & Nathanson, M. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587030 · Cited by 82
Yang, J. I., Yoon, J., Myung, S. J., Gwak, G., Kim, W. K., Chung, G. E., Lee, S. H., Lee, S., Kim, C. Y., & Lee, H.-S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.001 · Cited by 80
Heuman, D. M., Bajaj, R. S., & Lin, Q. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37599-4 · Cited by 79
Begovich, A. B., Klitz, W., Moonsamy, P. V., Van de Water, J., Peltz, G., & Gershwin, M. E. (1994) · Tissue Antigens · doi:10.1111/j.1399-0039.1994.tb02303.x · Cited by 78
The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
Schrumpf, E., Kummen, M., Valestrand, L., Greiner, T. U., Holm, K., Arulampalam, V., Reims, H. M., Baines, J., Bäckhed, F., Karlsen, T. H., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.020 · Cited by 77
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Wang, J. J., Yang, G.-X., Zhang, W. C., Lu, L., Tsuneyama, K., Kronenberg, M., Véla, J. L., Lopez-Hoyos, M., He, X.-S., Ridgway, W. M., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12224 · Cited by 74
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-1033-0 · Cited by 73
Pellicciari, R., Passeri, D., Franco, F., Mostarda, S., Filipponi, P., Colliva, C., Gadaleta, R. M., Franco, P., Carotti, A., Macchiarulo, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01126 · Cited by 72
Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00042-3 · Cited by 71
Cheng, J., Fang, Z.-Z., Kim, J.-H., Krausz, K. W., Tanaka, N., Chiang, J. L., & Gonzalez, F. J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m044420 · Cited by 71
Schwinge, D., Carambia, A., Quaas, A., Krech, T., Wegscheid, C., Tiegs, G., Prinz, I., Lohse, A. W., Herkel, J., & Schramm, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400076 · Cited by 70
Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes
Chang, J., Go, S., de Waart, D. R., Munoz‐Garrido, P., Beuers, U., Paulusma, C. C., & Oude Elferink, R. (2016) · Hepatology · doi:10.1002/hep.28550 · Cited by 70
Coordinate Transcriptional Regulation of Transport and Metabolism
Eloranta, J. J., Meier, P. J., & Kullak-Ublick, G. A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00028-5 · Cited by 69
Genome-Wide Association Studies in Primary Biliary Cirrhosis
Gulamhusein, A., Juran, B., & Lazaridis, K. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1567831 · Cited by 69
Self-citationTsuda, M., Ambrosini, Y. M., Zhang, W., Yang, G.-X., Ando, Y., Rong, G., Tsuneyama, K., Sumida, K., Shimoda, S., Bowlus, C. L., et al. (2011) · Hepatology · doi:10.1002/hep.24526 · Cited by 67
Lu, Y., Zhang, Z., Xiong, X., Wang, X., Li, J., Shi, G., Yang, J., Zhang, X., Zhang, H., Hong, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.029 · Cited by 67
Innate Immunity and Primary Biliary Cirrhosis
Selmi, C., Lleo, A., Pasini, S., Zuin, M., & Gershwin, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409787314525 · Cited by 65
Lee, M. Y., Choi, R., Kim, H. M., Cho, E. J., Kim, B. H., Choi, Y. S., Naowaboot, J., Lee, E. Y., Yang, Y. C., Shin, J. Y., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.10.066 · Cited by 64
Terasaki, S., Nakanuma, Y., OGINO, H., Unoura, M., & KOBAYASHI, K. P. (1991) · PubMed · Cited by 63
Zhang, H., Lian, M., Zhang, J., Bian, Z., Tang, R., Miao, Q., Peng, Y., Fang, J., You, Z., Invernizzi, P., et al. (2018) · Hepatology · doi:10.1002/hep.29418 · Cited by 61
Bae, H. R., Hodge, D. L., Yang, G., Leung, P. S. C., Chodisetti, S. B., Valencia, J. C., Sanford, M., Fenimore, J. M., Rahman, Z. S. M., Tsuneyama, K., et al. (2018) · Hepatology · doi:10.1002/hep.29524 · Cited by 60
TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
Keitel, V., Reich, M., & Häussinger, D. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8443-x · Cited by 59
Shoda, J., Inada, Y., Tsuji, A., Kusama, H., Ueda, T., Ikegami, T., Suzuki, H., Sugiyama, Y., Cohen, D. E., & Tanaka, N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400132-jlr200 · Cited by 58
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
Rodrigues, P. M., Perugorria, M. J., Santos-Laso, A., Bujanda, L., Beuers, U., & Banales, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.020 · Cited by 57
Breach of Tolerance: Primary Biliary Cirrhosis
Wang, L., Chang, C., Gershwin, M., & Wang, F.-S. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383729 · Cited by 56
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies
Kar, S. P., Seldin, M. F., Chen, W., Lu, E., Hirschfield, G. M., Invernizzi, P., Heathcote, J., Cusi, D., the Italian PBC Genetics Study Group, Almasio, P. L., et al. (2013) · Genes & Immunity · doi:10.1038/gene.2013.1 · Cited by 55
Self-citation
Research works printed but not linked: 1
- Cordell, H. J. et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun. 6, 8019 (2015). · DOI · Paper page
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“Recent clinical studies further indicate improvement of histological features, including fibrosis in patients with PBC after long-terms OCA treatment [305].”
BackgroundContribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 490
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationRecent advances in clinical practice: Epidemiology of autoimmune liver diseases
Trivedi, P. J., & Hirschfield, G. M. (2021) · Gut · doi:10.1136/gutjnl-2020-322362 · Cited by 244
Self-citation
Metadata
- Authors
- Gulamhusein, A. F., & Hirschfield, G. M.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Hirschfield, Gideon M.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-12-09
- Volume
- 17
- Issue
- 2
- Pages
- 93-110
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2993976670
- Cited by
- 308
- References
- 236
- Citations by year
- 2026: 29 · 2025: 55 · 2024: 62 · 2023: 57 · 2022: 53 · 2021: 33 · 2020: 19
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, pathogenesis, obeticholic acid, ursodeoxycholic acid, farnesoid X receptor, peroxisome proliferator-activated receptors, liver fibrosis, biliary cirrhosis, risk stratification, pruritus, nuclear receptor agonists, immunotherapy, cholestasis, cholangiocytes, epigenetic modifications
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Chenodeoxycholic Acid, Cholagogues and Choleretics, Environmental Exposure, Humans, Immunity, Innate, Liver Cirrhosis, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid, Autoimmunity, Receptors, Cytoplasmic and Nuclear, Disease Progression, Chloride-Bicarbonate Antiporters, Symporters, Organic Anion Transporters, Sodium-Dependent, MicroRNAs, Epigenesis, Genetic, Peroxisome Proliferator-Activated Receptors, Dihydrolipoyllysine-Residue Acetyltransferase, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.